KATY CAULFIELD: Open Payments
NPI 1174212427 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 32 payments from 17 companies in 2025. Trend: 2023 $168 · 2024 $470 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $199 |
| Stryker Corporation | 2 | $146 |
| Corcept Therapeutics | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $125 |
| Dexcom, Inc. | 1 | $122 |
| Lilly USA, LLC | 4 | $74 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $62 |
| Currax Pharmaceuticals LLC | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
Products named: MAKO, Korlym, RYBREVANT, EVENITY, Dexcom G6 Transmitter, Wegovy, JOURNAVX, CONTRAVE.
Industry payments across TX — which companies pay providers there.
